Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

12.15
Delayed Data
As of Jun 23
 +0.64 / +5.56%
Today’s Change
7.85
Today|||52-Week Range
45.20
-19.48%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close11.51
Today’s open11.47
Day’s range11.47 - 12.18
Volume1,651,428
Average volume (3 months)786,675
Market cap$527.6M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+7.56%
Earnings growth (this year)-12.31%
Earnings growth (next 5 years)--
Revenue growth (last year)+261.96%
P/E ratioNM
Price/Sales1,973.06
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...-0.09-1.18%
ACIUAC Immune Ltd+0.27+2.96%
RARXRa Pharmaceuticals I...+0.01+0.04%
CTMXCytomX Therapeutics ...+0.41+2.85%
Data as of 3:59pm ET, 06/23/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$330.7K
Annual profit (last year)-$116.4M
Net profit margin-35,205.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts